Breaking News

Wacker Opens Biologics Facility

Wacker's Jena site boasts doubled bio-production area and trebled purification capacity.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Wacker Chemie has opened a new production facility for biologics in Jena, Germany. The new plant is part of the Munich-based chemical company’s investment program to enlarge its biotech operations. The expansion, together with the new building for process development and quality control already completed last year, brings Wacker’s total investment in the Jena facility to some $24 million. Wacker has substantially boosted capacity at Jena in order to cope with a growing need for high-efficienc...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters